FDA Inspection 983868 — Stanford Health Care Transfusion Service
The FDA completed an inspection of Stanford Health Care Transfusion Service on Jul 26, 2016 in Palo Alto, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 26, 2016
- Fiscal Year
- 2016
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Palo Alto, CA (United States)